Compare Abeona Therapeutics Inc (ABEO) vs Mongodb Inc (MDB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Mongodb Inc — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Mongodb Inc trades at $358.76 (market cap $29.06B). The key difference: Mongodb Inc is far larger — about 77.8× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Mongodb Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | MDB | |
|---|---|---|
Market Cap | $373.32M | $29.06B |
Sector | Health | Technology |
52-Week High | $7.23 | $440.25 |
52-Week Low | $4.17 | $201.08 |
Enterprise Value | $228.22M | $26.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
MongoDB (MDB) trades at $361.32, up 1.81% with a bullish technical trend and strong analyst support. Recent earnings beats and revenue growth to $2.01B in 2025 highlight operational momentum, though profitability remains negative. The stock faces overbought signals near-term but benefits from AI-driven demand and raised 2026 guidance.
Outlook is positive with a $399.05 consensus price target, but risks include high valuation multiples, ongoing losses, and legal scrutiny. Investors should weigh robust growth against profitability challenges and market volatility for balanced exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →
